| Issue |
Section |
Title |
File |
| Vol 160, No 3 (2016) |
Article |
Antiepileptic Activity of a New Derivative of Benzimidazole RU-1205 |
|
| Vol 160, No 6 (2016) |
Pharmacology and Toxicology |
Effect of a New Antioxidant Enoxifol on Platelet Aggregation and Blood Rheological Properties in Rats with Experimental Diabetes Mellitus |
|
| Vol 162, No 5 (2017) |
Pharmacology and Toxicology |
Study of μ- and δ-Opioid Activities in Agents with Various κ-Receptor Selectivity |
|
| Vol 162, No 5 (2017) |
Article |
Antithrombotic Activity of DAB-15, a Novel Diazepinobenzimidazole Compound |
|
| Vol 162, No 6 (2017) |
Article |
Effect of Compound Sbt-828, a New Indole Derivative Exhibiting Antiaggregant Activity, on the Prostacyclin—Thromboxane A2 Balance |
|
| Vol 163, No 5 (2017) |
Article |
Effect of GRP119 Receptor Agonist, Compound MBX-2982, on Activity of Human Glucokinase |
|
| Vol 164, No 5 (2018) |
Article |
GABAergic Mechanism of Anticonvulsive Effect of Chemical Agent RU-1205 |
|
| Vol 166, No 6 (2019) |
Article |
Antithrombotic Activity of a Novel Diazepino[1,2-α] Benzimidazole Derivative on Arterial Thrombosis Model in Rats without Concomitant Pathology and in Rats with Experimental Myocardial Infarction |
|
